Evolent Health Inc.

9.66
0.19 (2.01%)
At close: Apr 01, 2025, 3:59 PM
9.63
-0.33%
After-hours: Apr 01, 2025, 08:00 PM EDT

Evolent Health Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue 2.55B 1.96B 1.35B 907.96M 1.02B
Cost of Revenue 2.19B 1.5B 1.04B 657.55M 701.37M
Gross Profit 367.35M 460.47M 316.58M 250.41M 321.06M
Operating Income -40.48M -71.21M -59.84M 30.25M -37.88M
Interest Income 5.54M 5.26M 1.37M 407K 3.16M
Pretax Income -63.04M -202.41M -62.08M -29.8M -337.8M
Net Income -61.62M -113.04M -18.7M -30.28M -334.25M
Selling & General & Admin 263.05M 358.11M 269.27M 219.5M 310.55M
Research & Development n/a n/a 27M 15.5M 15.1M
Other Expenses 144.79M 173.57M 67.19M 60.04M 61.48M
Operating Expenses 407.84M 531.68M 336.46M 279.54M 372.03M
Interest Expense 24.72M 54.2M 15.57M 25.43M 28.34M
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 2.6B 2.04B 1.37B 937.09M 1.07B
Income Tax -1.41M -89.36M -43.38M 483K -3.55M
Shares Outstanding (Basic) 114.68M 111.25M 93.7M 86.07M 84.93M
Shares Outstanding (Diluted) 114.68M 111.25M 93.7M 86.07M 84.93M
EPS (Basic) -0.81 -1.28 -0.2 -0.35 -3.94
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA 80.06M -24.79M 43.75M 55.66M -241.38M
Depreciation & Amortization 118.37M 123.42M 90.25M 60.04M 60.84M